![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 NOVO NORDISK A/S (6)
02 Novo Nordisk A/S (6)
03 Novo Nordisk Pharma AG (9)
01 Novorapid (19)
02 degludec; Novorapid (2)
01 Italy (6)
02 Norway (6)
03 Switzerland (9)
01 Injection (8)
02 Injection fluid, resolution (1)
03 Injection fluid, resolution in sylinderampulle (1)
04 Injection fluid, resolution in the finished filled pen (1)
05 Injection fluid, resolution in the hood glass (1)
06 Injection fluid, suspension (2)
07 Insulin Aspart 160U 1,6Ml 5 Units Parenteral Use (1)
08 Insulin Aspart 300Iu 3Ml 5 Units Parenteral Use (2)
09 Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 30/70 300Iu 3Ml 5 Units Parenteral Use (1)
10 Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 50/50 300Iu 3Ml 5 Units Parenteral Use (1)
11 Soluble Insulin Aspart+Insulin Aspart Crystallised Protamino 70/30 300Iu 3Ml 5 Units Parenteral Use (1)
12 Solution (1)